Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Anthony Mark Mccamish > Profile

Anthony Mark Mccamish

Affiliations

  • Director at Avadel Pharmaceuticals Plc (AVDL), 2024-08-01
  • Director at Rafael Holdings Inc. (RFL), 2024-01-08
  • Director at Vincera Pharma Inc. (VINC), 2020-12-29
  • President And Ceo at Forty Seven Inc. (FTSV), 2020-04-07
  • Officer at Facet Biotech Corp (FACT), 2009-02-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Avadel Pharmaceuticals Plc
 AVDL $5.83 52,398 Director 171,000 2020-09-17 Filing
Avadel Pharmaceuticals Plc
 AVDL $5.73 118,602 Director 118,602 2020-09-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Avadel Pharmaceuticals Plc
 AVDL $14.53 75,000 Director 67,025 2023-12-28 Filing
Avadel Pharmaceuticals Plc
 AVDL $14.93 28,975 Director 142,025 2023-08-11 Filing
Forty Seven Inc.
 FTSV $95.42 30,237 Officer, Director 4,595 2020-04-01 Filing
Forty Seven Inc.
 FTSV $95.41 2,340 Officer, Director 34,832 2020-04-01 Filing
Forty Seven Inc.
 FTSV $11.02 8,199 Officer, Director 60,719 2019-06-25 Filing